ChemoCentryx
ChemoCentryx, Inc. (NASDAQ: CCXI) is a biopharmaceutical company founded in 1997 commercializing and developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx target...load more
ChemoCentryx's Basic Information
Industry
Headquarters
San Carlos, Arizona, United States
Website
Founded Year
1997
Headcount
51 - 200 ( View All )
Specialties
Biopharmaceuticaloral therapiesautoimmune diseasesinflammatory disordersorphan and rare diseasesPancreatic CancerDiabetic NephropathyANCA-associated vasculitisatypical hemolytic uremic syndromechemokine and chemoattractant receptorsTAVNEOSFocal Segmental Glomerulosclerosisoral therapeuticsimmuno-oncologyHidradenitis SuppurativaChronic Kidney DiseaseC3 GlomerulopathySmall Molecule TherapeuticsChemoattractant SystemChemokineDrug DiscoveryInflammatory Bowel Disease (IBD)Rheumatoid Arthritis (RA)AvacopanComplement ReceptorADVOCATEAURORALUMINA
ChemoCentryx's Competitors
Employee Insights
ChemoCentryx's Top Employees
Yandong Li
Associate Scientist II AT Chemocentryx
Phone Email
Alexander Reiss
Research Associate
Phone Email
Alice Liu
Research Associate
Phone Email
Carolyn Dunlap
Research Associate
Phone Email
Ashton Easterday
Senior Associate Scientist, Dmpk
Phone Email
Frequently Asked Questions Regarding ChemoCentryx
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts